A study of chlorhexidine and metronidazole plus FB301 for bacterial vaginosis
Treatments studied
Part of Infections, Women’s health & pregnancy clinical trials.
This trial tests a pre-treatment with chlorhexidine and/or metronidazole before a new drug called FB301 in women with bacterial vaginosis (BV). It aims to see if this combination is safe and works well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 45 years old, before menopause.
- You have untreated bacterial vaginosis with a fishy odor or unusual discharge, confirmed by a doctor's test.
- Your body mass index (BMI) is 37 or lower.
- You are willing to stop vaginal intercourse, use of tampons, menstrual cups, and other vaginal products for a short time during the trial.
- You are not pregnant, breastfeeding, or planning to become pregnant in the next 6 months.
- You have not used antibiotics in the vagina or by mouth in the last 30 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a probiotic (friendly bacteria) treatment for postmenopausal women who have bacterial vaginosis. It aims to see if the probiotic can improve vaginal health.
This study tests whether a vaginal probiotic called Gyntima Balance can help prevent bacterial vaginosis from coming back. If you have had repeat infections, this might be a way to reduce future episodes.
This study tests a medical device called Vagitab-T as an extra treatment for women with bacterial vaginosis who are already taking the antibiotic metronidazole. It may help prevent the infection from coming back.
This study tests two new investigational drugs to treat bacterial vaginosis. It aims to see if these drugs are safe and work well. If you have BV, this trial could give you access to a new treatment option.
This trial tests a new vaginal capsule called BPR-101, given together with the antibiotic metronidazole, to treat bacterial vaginosis (BV). If you have BV, this study aims to see if the combination is safe and effective in clearing the infection.
This trial tests whether transplanting “good bacteria” into the vagina can treat recurrent bacterial vaginosis (BV). It may help restore a healthier vaginal bacterial balance and reduce BV episodes.
Hear when a new Bacterial Vaginosis (BV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.